De Scheerder Pharmaceuticals
0752.564.602 · rovalta.com · 25/09/2026
De Scheerder Pharmaceuticals
Financial year 2025 · Closed on 30/06/2025
Overview
Identity
Source · BCE/KBODe Scheerder Pharmaceuticals is a Private limited company incorporated in 2020. Its main activity is: Other business support service activities n.e.c.. Its registered office is in Gent.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0752.564.602
- Incorporation
- 13/08/2020
- Legal form
- Private limited company
- Registered office
- Mariakerkegeest 12
9030 Gent · FlandreSee on map - Contributed capital
- 5 000,00 €
- Latest accounts
- 30/06/2025
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 33,1 k € | +79.6% | 18,4 k € | -39.3% | 30,4 k € | +400% | 6,1 k € | -24.6% | 8,1 k € |
| EBITDA | 32,5 k € | +83.5% | 17,7 k € | -40.5% | 29,8 k € | +426% | 5,7 k € | -22.2% | 7,3 k € |
| Operating result | 32,1 k € | +80.9% | 17,7 k € | -40.5% | 29,8 k € | +456% | 5,4 k € | -2.9% | 5,5 k € |
| Net result | 25,1 k € | +83.7% | 13,7 k € | -41.4% | 23,4 k € | +500% | 3,9 k € | -1.7% | 4 k € |
| Balance sheet | |||||||||
| Equity | 68,4 k € | +52.0% | 45 k € | +36.4% | 33 k € | +193% | 11,3 k € | +37.9% | 8,2 k € |
| Total assets | 71,7 k € | +45.2% | 49,4 k € | +34.1% | 36,8 k € | +139% | 15,4 k € | +31.6% | 11,7 k € |
| Cash | 60,6 k € | +56.4% | 38,7 k € | +52.6% | 25,4 k € | +285% | 6,6 k € | -39.1% | 10,8 k € |
| Debts | 3,3 k € | -25.0% | 4,4 k € | +14.2% | 3,8 k € | -7.6% | 4,1 k € | +17.1% | 3,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/06/20251 active
Active mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 13/08/2020 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 11 months |
| Filing date | 17/01/2026 | 17/01/2025 | 29/01/2024 | 29/01/2023 | 20/12/2021 |
| General meeting | 17/12/2025 | 18/12/2024 | 30/12/2023 | 30/12/2022 | 15/12/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 5 filingsValuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other17/08/2020RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202525,1 k €↑
- 2024Annual accounts 202413,7 k €↓
- 2023Annual accounts 202323,4 k €↑
- 2022Annual accounts 20223,9 k €↓
- 2021Annual accounts 20214 k €
- 13/08/2020IncorporationPrivate limited company